Switch to:
More From Other Websites
Superbugs Turn Big Pharma, Gov't Focus To Antibiotics Apr 09 2015
Mario Gabelli's Top 5 Stock Picks Mar 31 2015
Farallon Capital Starts New Position in Cubist Pharmaceuticals Mar 20 2015
Elliott Management exits position in Covidien Mar 04 2015
Elliott Management starts new position in Cubist Pharmaceuticals Mar 02 2015
Prem Watsa's Stock Buys and Sells of Q4 Feb 17 2015
FDA approves Cubists' drug for antibiotic-resistant bacteria Dec 19 2014
Cubist sales force seen as potential boon for Merck intestinal drug Dec 10 2014
Cubist sales force seen as potential boon for Merck intestinal drug Dec 09 2014
Cubist sales force seen as potential boon for Merck intestinal drug Dec 09 2014
Merck says still plans to buy Cubist, despite patent setback Dec 09 2014
Merck committed to Cubist after patent losses Dec 09 2014
Merck committed to Cubist after patent losses Dec 09 2014
Merck says still plans Cubist purchase, despite patent setback Dec 09 2014
After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired? Dec 09 2014
Merck to take on superbugs with Cubist Pharma buy Dec 08 2014
Merck dives into 'superbug' chase with Cubist Dec 08 2014
Merck dives into 'superbug' chase with Cubist Dec 08 2014
Merck to buy Cubist Pharmaceuticals for $8.4 billion Dec 08 2014
Court rules Hospira can launch generic Cubicin in 2016 Dec 08 2014


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK